The blind spot
University-originated hard-tech startups often begin with real invention. The science may be impressive. The publications may be credible. The professor or student founder may know the mechanism deeply.
That does not mean the company knows what business it is in. Invention logic and company logic are different. A university result asks, "Is this novel and publishable?" A startup must answer, "Who buys, why now, how is it made, what can be defended, and what milestone deserves capital?"
Warning signs
Watch for broad market claims, no first product wedge, weak customer discovery, vague manufacturing path, overreliance on patents, and milestones built around more technical proof rather than customer or manufacturing risk reduction.
Another common problem: the team is still optimizing for scientific completeness when the company needs commercial sequence. The first product does not have to express the full invention. It has to create a beachhead.
What good evidence looks like
Good evidence includes a narrow first market, a specific buyer, a painful bottleneck, credible manufacturing assumptions, a realistic funding path, and proof milestones that reduce investor-relevant uncertainty.
The best founders can explain not only why the invention is powerful, but what they will not pursue first.
TIGRE lens
TIGRE pressure-tests whether the startup has crossed from invention into company formation logic. The goal is not to dilute the technical substance. The goal is to make it fundable, manufacturable, and sellable.